KLRS Q4 2020 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$18,000

Operating Income

-$25M

Net Income

-$25M

EPS (Diluted)

$-9.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$371M

Total Liabilities

$18M

Stockholders' Equity

$353M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$18,000	-$19,000	+5.3%
Operating Income	-$25M	-$10M	-167.4%
Net Income	-$25M	-$9M	-188.2%